[ad_1] Image source: Getty Images There’s definitely nothing wrong with having some cash set aside for a rainy day (or sudden emergency). But the last couple of years have taught us that this can lose value over time, due to the eroding power of inflation. With interest rates on savings accounts likely to continue falling in 2025, I think investors can aim to generate far more passive income via the stock market. First steps Getting started requires opening an investment account. One option is a Stocks and Shares ISA. This allows UK investors to put up to £20,000 to work…
Author: user
[ad_1] The main point of investing for the long term is to make money. Furthermore, you’d generally like to see the share price rise faster than the market. Unfortunately for shareholders, while the Escalade, Incorporated (NASDAQ:ESCA) share price is up 47% in the last five years, that’s less than the market return. The last year has been disappointing, with the stock price down 29% in that time. So let’s investigate and see if the longer term performance of the company has been in line with the underlying business’ progress. Check out our latest analysis for Escalade While the efficient markets…
[ad_1] LONDON – JPMorgan Global Growth & Income PLC has announced the issuance of 75,000 Ordinary Shares at a price of 579.60 pence per share, according to a statement released today. The shares were sold for cash under the company’s Ordinary Share block listing facility that was established on May 24, 2024. Following this transaction, JPMorgan Global Growth & Income PLC’s total issued share capital stands at 510,802,308 shares. This figure is now the reference point for shareholders to determine if they need to disclose changes in their stake in the company as per the Financial Conduct Authority’s Disclosure Guidance…
[ad_1] https://www.tipranks.com/news/company-announcements/novartis-gene-therapy-shows-promise-in-treating-sma Novartis ( (NVS) ) has provided an update. Novartis announced the success of its Phase III STEER study for investigational intrathecal onasemnogene abeparvovec (OAV101 IT) in treating spinal muscular atrophy (SMA) Type 2 in children and young adults. The study demonstrated an increase in motor function, showcasing the therapy’s efficacy and safety compared to a sham control. Novartis plans to seek regulatory approval in 2025, which could enhance treatment options for SMA patients and strengthen the company’s position in gene therapy innovation. More about Novartis Novartis AG is a global healthcare company based in Basel, Switzerland, specializing in…
[ad_1] Cars pass under toll machines on Broadway Avenue in the Manhattan borough of New York City on November 14, 2024. Charly Triballeau | AFP | Getty ImagesWith just days to go before the nation’s first congestion toll begins in New York City, the pricing plan may have passed its final hurdle in a ruling from a U.S. district court who heard a suit from the state of New Jersey on environmental grounds, according to the MTA. But an attorney for the state of New Jersey says not so fast.While the judge ruled the Federal Highway Administration (FHWA) will need to weigh in,…
[ad_1] Image source: Getty Images As we survey the global stock market winners and losers of 2024, it’s fair to say that Tesla (NASDAQ: TSLA) occupies the former category. But how much would an investor have made if they’d bought £20,000 worth of the electric car company’s shares at the beginning of the year? And would they be wise to quit while they’re ahead? Ending 2024 with a flurry Tesla’s massive 68% gain belies the fact that the vast majority of this return only came in the last couple of months. For much of the year, the stock has been…
[ad_1] LONDON – Amundi Physical Metals plc has announced the issuance of a new tranche of exchange-traded commodities (ETCs) under its Amundi Physical Gold ETC, which offers investors exposure to the price movements of gold. The new tranche, number 639, consists of 28,000 ETC Securities and follows the issuance pattern under the company’s Secured Precious Metal Linked ETC Securities Programme. The ETC Securities are designed to provide investors with a direct exposure to gold prices without the necessity of taking physical delivery of the metal. Each ETC Security issued by Amundi is backed by a specific amount of gold, with…
[ad_1] Investing.com – European stock markets inched higher Tuesday, in thin holiday-impacted volumes on the final reading session of the year. At 04:40 ET (09:40 GMT), the CAC 40 in France gained 0.3% and the in the U.K. rose 0.2%, while the in Germany was closed. Trading volumes were limited early in the session, with bourses in Italy and Switzerland joining Germany in shutting on New Year’s Eve, while those in France, Spain and the UK set for an early close. European underperformance The main European indices have struggled in the final quarter of the year, weighed by political uncertainties,…
[ad_1] On Monday, BTIG analysts maintained a Neutral rating on Vacasa Inc (NASDAQ:VCSA) following the announcement of its acquisition by Casago, a private company. The acquisition, which is expected to be finalized between the first and second quarters of 2025, values Vacasa at approximately $129 million in equity and around $135 million in enterprise value. The offer price is set at $5.02 per share in cash, representing a premium to the current market cap of $85.55 million. According to InvestingPro data, the stock has shown a significant 7.93% return over the last week as investors react to the news. BTIG’s…
[ad_1] If we’re trying to summarise the global stock market performance for 2024, it’s hard to ignore Nvidia (NASDAQ:NVDA) stock. The share price has soared 191% this year, propelling the market cap to a staggering $3.43trn. The focus turns to 2025, where all eyes will be on the company to help keep positive market sentiment going. Here’s what I think could happen next year. A high benchmark During the release of quarterly results throughout the year, Nvidia managed to beat analyst expectations. However, as the year went on, the size — percentage-wise — of the outperformance decreased as the firm…